Acetylcholinesterase inhibition affects cardiovascular structure in mice

Physiological Research

Volumn 55, Issue SUPPL. 1, 2006, Pages

  Bernatova I ^a,b   Babal P ^c   Grubbs, R D ^a   Morris, M ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c Physics and Informatics   (Slovakia)

Author keywords

Apoptosis; Blood pressure; Heart rate; Pyridostigmine; Stress reactivity; Vascular structure

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; CORTICOSTERONE; PYRIDOSTIGMINE;

ANIMAL; AORTA; APOPTOSIS; ARTICLE; BLOOD; BLOOD PRESSURE; C57BL MOUSE; CARDIOVASCULAR SYSTEM; DRUG EFFECT; HEART; HEART MUSCLE; HEART RATE; MALE; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; STRESS;

ACETYLCHOLINESTERASE; ANIMALS; AORTA; APOPTOSIS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CHOLINESTERASE INHIBITORS; CORTICOSTERONE; HEART; HEART RATE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; PYRIDOSTIGMINE BROMIDE; STRESS;

EID: 33847128846     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. ARSTALL MA, SAWYER DB, FUKAZAWA R, KELLY RA: Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 85: 829-840, 1999.
2. BECK KD, BRENNAN FX, MOLDOW RL, OTTENWELLER JE, ZHU G, SERVATIUS RJ: Stress interacts with peripheral cholinesterase inhibitors to cause central nervous system effects. Life Sci 73: 41-51, 2003.
3. BERNÁTOVÁ I, PECHÁŇOVÁ O, KRISTEK F: Mechanism of structural remodelling of the rat aorta during long-term NG-nitro-L-arginine methyl ester treatment. Jpn J Pharmacol 81: 99-106, 1999.
4. BERNÁTOVÁ I, KEY MP, LUCOT JB, MORRIS M: Circadian differences in stress-induced pressor reactivity in mice. Hypertension 40: 768-773, 2002.
5. BERNÁTOVÁ I, DUBOVICKY M, PRICE WA, GRUBBS RD, LUCOT JB, MORRIS M: Effect of chronic pyridostigmine bromide treatment on cardiovascular and behavioral parameters in mice. Pharmacol Biochem Behav 74: 901-907, 2003.
6. BERNÁTOVÁ I, RIGATTO KV, KEY MP, MORRIS M: Stress-induced pressor and corticosterone responses in oxytocin-deficient mice. Exp Physiol 89: 549-557, 2004.
7. BERNÁTOVÁ I, BABÁL P, GRUBBS RD, MORRIS M: Acetylcholinesterase inhibition affects cardiovascular structure in mice. Physiol Res 54: 52P, 2005.
8. BREYER-PFAFF U, MAIER U, BRINKMANN AM, SCHUMM F: Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis. Clin Pharmacol Ther 37: 495-501, 1985.
9. CASTRO RR, PORPHIRIO G, SERRA SM, NOBREGA AC: Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease. Braz J Med Biol Res 35: 685-689, 2002.
10. CHAN RY, ADATIA FA, KRUPA AM, JASMIN BJ: Increased expression of acetylcholinesterase T and R transcripts during hematopoietic differentiation is accompanied by parallel elevations in the levels of their respective molecular forms. J Biol Chem 273: 9727-9733, 1998.
11. CHOY JC, GRANVILLE DJ, HUNT DW, MCMANUS BM: Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol. 33: 1673-1690, 2001.
12. COLEMAN BA, TAYLOR P: Regulation of acetylcholinesterase expression during neuronal differentiation. J Biol Chem 271: 4410-4416, 1996.
13. DANIHEL L, GOMOLČÁK P, KORBEL M, PRUŽINEC J, VOJTASSÁK J, JANÍK P, BABÁL P: Expression of proliferation and apoptotic markers in human placenta during pregnancy. Acta Histochem 104: 335-338, 2002.
14. DAS A, KAPOOR K, SAYEEPRIYADARSHINI AT, DIKSHIT M, PALIT G, NATH C: Immobilization stress-induced changes in brain acetylcholinesterase activity and cognitive function in mice. Pharmacol Res 42: 213-217, 2000.
15. DIMMELER S, HAENDELER J, RIPPMANN V, NEHLS M, ZEIHER AM: Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett 399: 71-74, 1996.
16. FARAH VM, JOAQUIM LF, BERNÁTOVÁ I, MORRIS M: Acute and chronic stress influence blood pressure variability in mice. Physiol Behav 83: 135-142, 2004.
17. GARG UC, HASSID A: Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells. Eur J Pharmacol 237: 243-249, 1993.
18. GRABE-GUIMARAES A, ALVES LM, TIBIRICA E, NOBREGA AC: Pyridostigmine blunts the increases in myocardial oxygen demand elicited by the stimulation of the central nervous system in anesthetized rats. Clin Auton Res 9: 83-89, 1999.
19. HALEY RW, VONGPATANASIN W, WOLFE GI, BRYAN WW, ARMITAGE R, HOFFMANN RF, PETTY F, CALLAHAN TS, CHARUVASTRA E, SHELL WE, MARSHALL WW, VICTOR RG: Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome. Am J Med 117: 469-478, 2004.
20. HO FM, LIU SH, LIAU CS, HUANG PJ, SHIAH SG, LIN-SHIAU SY: Nitric oxide prevents apoptosis of human endothelial cells from high glucose exposure during early stage. J Cell Biochem 75: 258-263, 1999.
21. ING DJ, ZANG J, DZAU VJ, WEBSTER KA, BISHOPRIC NH: Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res 84: 21-33, 1999.
22. JEYARASASINGAM G, YELUASHVILI M, QUIK M: Nitric oxide is involved in acetylcholinesterase inhibitorinduced myopathy in rats. J Pharmacol Exp Ther 295: 314-320, 2000.
23. JEŽOVÁ D, ŠKULTETYOVÁ I, TOKAREV DI, BAKOŠ P, VIGAŠ M: Vasopressin and oxytocin in stress. Ann NY Acad Sci 771: 192-203, 1995.
24. JOAQUIM LF, FARAH VM, BERNATOVA I, FAZAN R JR., GRUBBS R, MORRIS M: Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice. Am J Physiol 287: H251-H257, 2004.
25. KATO T, SUGIYAMA S, HANAKI Y, FUKUSHIMA A, AKIYAMA N, ITO T, OZAWA T: Role of acetylcholine in pyridostigmine-induced myocardial injury: possible involvement of parasympathetic nervous system in the genesis of cardiomyopathy. Arch Toxicol 63: 137-143, 1989.
26. KEELER JR, HURST CG, DUNN MA: Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 266: 693-695, 1991.
27. KELLY RA, BALLIGAND JL, SMITH TW: Nitric oxide and cardiac function. Circ Res 79: 363-380, 1996.
28. KOLPAKOV V, GORDON D, KULIK TJ: Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 76: 305-309, 1995.
29. KUNEŠ J, HOJNÁ S, KADLECOVÁ M, DOBEŠ OVÁ Z, RAUCHOVÁ H, VOKURKOVÁ M, LOUKOTOVÁ J, PECHÁ?OVÁ O, ZICHA J: Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol Res 53 (Suppl 1): S23-S34, 2004.
30. LI P, SUR SH, MISTLBERGER RE, MORRIS M: Circadian blood pressure and heart rate rhythms in mice. Am J Physiol 276: R500-R504, 1999.
31. MORRIS M, LI P, BARRETT C, CALLAHAN MF: Oxytocin antisense reduces salt intake in the baroreceptor-denervated rat. Regul Pept 59: 261-266, 1995.
32. NOBREGA AC, DOS REIS AF, MORAES RS, BASTOS BG, FERLIN EL, RIBEIRO JP: Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin Auton Res 11: 11-17, 2001.
33. PECHÁŇOVÁ O, BERNÁTOVÁ I, PELOUCH V, BABÁL P: L-NAME-induced protein remodeling and fibrosis in the rat heart. Physiol Res 48: 353-362, 1999.
34. RAJ SR, BLACK BK, BIAGGIONI I, HARRIS PA, ROBERTSON D: Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 111: 2734-2740, 2005.
35. SANT'ANNA ID, DE SOUSA EB, DE MORAES AV, LOURES DL, MESQUITA ET, DA NOBREGA AC: Cardiac function during mental stress: cholinergic modulation with pyridostigmine in healthy subjects. Clin Sci 105: 161-165, 2003.
36. SARTI P, ARESE M, GIUFFRE A: The molecular mechanisms by which nitric oxide controls mitochondrial complex IV. Ital J Biochem 52: 37-42, 2003.
37. SINTON CM, FITCH TE, PETTY F, HALEY RW: Stressful manipulations that elevate corticosterone reduce bloodbrain barrier permeability to pyridostigmine in the Rat. Toxicol Appl Pharmacol 165: 99-105, 2000.
38. SOARES PP, DA NOBREGA AC, USHIZIMA MR, IRIGOYEN MC: Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton Neurosci 113: 24-31, 2004.
39. SUETA CA: Heart rate variability in chronic heart failure: target for therapy? Am Heart J 146: 385-387, 2003.
40. TÖRÖK J, KRISTEK F: Beneficial effect of pentaerythrityl tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition. Vascul Pharmacol 38: 177-182, 2002.
41. UCHIYAMA T, OTANI H, OKADA T, NINOMIYA H, KIDO M, IMAMURA H, NOGI S, KOBAYASHI Y: Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes. J Mol Cell Cardiol 34: 1049-1061, 2002.
42. ZHANG XJ, YANG L, ZHAO Q, CAEN JP, HE HY, JIN QH, GUO LH, ALEMANY M, ZHANG LY, SHI YF: Induction of acetylcholinesterase expression during apoptosis in various cell types. Cell Death Differ 9: 790-800, 2002.